Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001058501 | SCV001223077 | likely benign | Carnitine palmitoyltransferase II deficiency | 2023-12-16 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001058501 | SCV002090284 | uncertain significance | Carnitine palmitoyltransferase II deficiency | 2020-08-07 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003906166 | SCV004727516 | likely benign | CPT2-related disorder | 2022-01-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |